Since the combination of anti-PD-1 and anti-CTLA-4 antibody treatment has been shown to be more effective than anti-PD-1 alone treatment in the RENCA tumor model,32 we combined both anti-CTLA-4 and anti-PD-1 antibodies with the vaccine. The gene discussed is PDCD1; the disease is neoplasm.